Comparison of Vitamin E and Propionyl-L-Carnitine, Separately or in Combination, in Patients With Early Chronic Peyronie's Disease: A Double-Blind, Placebo Controlled, Randomized Study

Journal of Urology

Volumn 178, Issue 4, 2007, Pages 1398-1403

  Safarinejad, Mohammad Reza ^a   Hosseini, Seyyed Yousof ^a   Kolahi, Ali Asgar ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

carnitine; drug therapy; penile induration; vitamin E

Indexed keywords

ALPHA TOCOPHEROL; PLACEBO; PROPIONYLCARNITINE;

ADULT; ARTICLE; CLINICAL TRIAL; COITUS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; HUMAN; MAJOR CLINICAL STUDY; MALE; PAIN ASSESSMENT; PEYRONIE DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VISUAL ANALOG SCALE;

ADMINISTRATION, ORAL; ADULT; CARNITINE; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PAIN MEASUREMENT; PENILE ERECTION; PENILE INDURATION; VITAMIN E;

EID: 34548457714     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2007.05.162     Document Type: Article

References (19)

1. Carson III C.C., Gelhard M.K., and Jordan G.H. Peyronie's disease: New concepts in etiology, diagnosis, and treatment. Contemp Urol 11 (1999) 44
2. Udelson D., Nehra A., Hatzichristou D.G., Azadzoi K., Moreland R.B., Krane J., et al. Engineering analysis of penile hemodynamic and structural dynamic relationships: part I - clinical implications of penile tissue mechanical properties. Int J Impot Res 10 (1998) 15
3. Hellstrom W.J.G., and Bivalacqua T.J. Peyronie's disease: etiology, medical, and surgical therapy. J Androl 21 (2000) 347
4. Gholami S.S., Gonzalez-Cadavid N.F., Lin C.S., Rajfer J., and Lue T.F. Peyronie's disease: a review. J Urol 169 (2003) 1234
5. Safarinejad M.R. Therapeutic effects of colchicine in the management of Peyronie's disease: a randomized double-blind, placebo-controlled study. Int J Impot Res 16 (2004) 238
6. El-Sakka A.I., Selph C.A., Yen T.S.B., Dahiya R., and Lue T.F. The effect of surgical trauma on rat tunica albuginea. J Urol 159 (1998) 1700
7. Block E.R. Hydrogen peroxide alters the physical state and function of the plasma membrane of pulmonary artery endothelial cells. J Cell Physiol 146 (1991) 362
8. Scott W., and Scardino P. A new concept in the treatment of Peyronie's disease. South Med J 41 (1948) 173
9. Prieto Castro R.M., Leva Vallejo M.E., Regueiro Lopez J.C., Anglada Curado F.J., Alvarez Kindelan J., and Requena Tapia M.J. Combined treatment with vitamin E and colchicine in the early stages of Peyronie's disease. BJU Int 91 (2003) 522
10. Van Hinsbergh V.W.M., and Scheffer M.A. Effect of propionyl-L-carnitine on human endothelial cells. Cardiovasc Drugs Ther 5 (1991) 97
11. Cavallini G., Biagiotti G., Koverech A., and Vitali G. Oral propionyl-l-carnitine and intraplaque verapamil in the therapy of advanced and resistant Peyronie's disease. BJU Int 89 (2002) 895
12. Rosen R.C., Riley A., Wagner G., Osterloh I.H., Kirkpatrick J., and Mishra A. The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 49 (1997) 822
13. Kelami A. Classification of congenital and acquired penile deviation. Urol Int 38 (1983) 822
14. Kim S.W., and Paick J.S. Short-term analysis of the effects of as needed use of sertraline at 5 pm for the treatment of premature ejaculation. Urology 54 (1999) 544
15. Biagiotti G., and Cavallini G. Acetyl-L-carnitine vs tamoxifen in the oral therapy of Peyronie's disease: a preliminary report. BJU Int 88 (2001) 63
16. Mynderse L.A., and Monga M. Oral therapy for Peyronie's disease. Int J Impot Res 14 (2000) 340
17. Pryor J.P., and Farrel C.R. Controlled clinical trial of vitamin E in Peyronie's disease. Prog Reprod Biol Med 9 (1983) 41
18. Devine Jr. C.J., and Horton C.E. Bent penis. Semin Urol 5 (1987) 251
19. Devine Jr. C.J. Introduction. International Conference on Peyronie's Disease. J Urol 157 (1997) 272